A utility-based Bayesian phase I--II design for immunotherapy trials with progression-free survival end point
From MaRDI portal
Publication:6642064
DOI10.1111/RSSC.12288MaRDI QIDQ6642064
Author name not available (Why is that?)
Publication date: 21 November 2024
Published in: (Search for Journal in Brave)
No records found.
No records found.
This page was built for publication: A utility-based Bayesian phase I--II design for immunotherapy trials with progression-free survival end point
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6642064)
